feed,title,long_url,short_url
Benzinga,Pharma Stock Shoots Up As FDA Accepts NDA For Neuromuscular Disorder Drug Under Priority Review,https://benzinga.com/general/biotech/22/05/27416038/pharma-stock-shoots-up-as-fda-accepts-nda-for-neuromuscular-disorder-drug-under-priority-review,https://bit.ly/39YbLVd
Benzinga,Pfizer's Combo Therapy For Fatty Liver Disease Gets FDA Fast Track Status,https://benzinga.com/general/biotech/22/05/27415212/fda-grants-fast-track-designation-to-pfizers-combination-therapy-for-nash,https://bit.ly/38UyS2R
Benzinga,Tesla Stock Gets Another Price Target Cut â€” This Time From Jefferies,https://benzinga.com/analyst-ratings/analyst-color/22/05/27411697/tesla-analyst-says-stock-woes-is-due-to-disruptions-from-inside-resolution-depends-,https://bit.ly/3z18Kyb
